Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05416814 · ClinicalTrials.gov registry record · Early Phase 1
Safety and Feasibility of Kefir Administration in Critically Ill Adults
A Early Phase 1 study of Critically Ill, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT05416814: Completed Early Phase 1 study of Critically Ill, sponsored by Mayo Clinic.
NCT05416814 is a Early Phase 1 study of Critically Ill that has completed, run by Mayo Clinic. The registered enrollment target is 54 participants, below the 882-participant average among 7 other Critically Ill trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05416814, a Early Phase 1 study of Critically Ill, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and feasibility of kefir administration in critically ill adults.
Primary Outcome
Number of adverse effects related to kefir administration including vomiting, aspiration, diarrhea, interactions with medications or tube feeds, bacteremia secondary to a bacterium in kefir
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Kefir
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2023-12-03 |
| Phase | Early Phase 1 |
What the finished NCT05416814 record still lists
NCT05416814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 882-participant average among 7 other Critically Ill trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Critically Ill appearing as the primary indexed condition, and to 1 intervention - of which Kefir is the first listed.
NCT05416814 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05416814 about?
NCT05416814 is a clinical study titled "Safety and Feasibility of Kefir Administration in Critically Ill Adults". The purpose of this study is to evaluate the safety and feasibility of kefir administration in critically ill adults.
What is the current status of trial NCT05416814?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 54 participants. The study started on 2022-07-12. Estimated completion is 2023-12-03.
What conditions does trial NCT05416814 study?
This clinical trial studies the following conditions: Critically Ill.
What interventions are being tested in trial NCT05416814?
The interventions under investigation include: Kefir (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05416814?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05416814 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critically Ill
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
RECRUITING
-
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
RECRUITING
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
COMPLETED · NA
-
New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children
COMPLETED
-
Managing Acute Pain in Critically Ill Non-communicative Palliative Care Patients
COMPLETED · NA
-
A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI